Where does Jernej Godec work?

Jernej Godec is Principal at Atlas Venture.

What does Jernej Godec invest in?

Jernej Godec invests in Biotech.

What check size does Jernej Godec write?

Jernej Godec typically writes checks of $10M – $50M.

Where did Jernej Godec go to school?

Jernej Godec studied at Harvard University (Ph.D., Immunology); University of California, Berkeley (B.A., with Honors in Molecular and Cell Biology).

Jernej Godec

Investor

Principal at Atlas Venture

Cambridge, Massachusetts

Writes $10M – $50M checks · typically $25M

About

Jernej Godec is a Principal at Atlas Venture, where he works on building therapeutics companies and supporting company creation across multiple therapeutic areas. Before Atlas, he was on the investment team at Apple Tree Partners, focused on early-stage therapeutics investments and company formation. He holds a PhD in immunology from Harvard University, where he studied T cell biology, and a BA with honors in molecular and cell biology from UC Berkeley.

Contact· published on Jernej's own website

j•••@atlasventure.comreveal

Invests in

Biotech

Experience

Atlas VenturePrincipalcurrent2021 — presentCambridge, Massachusetts, United States
Atlas VentureSenior Associate2021Cambridge, Massachusetts, United States
Atlas VentureAssociate2019 — 2021Cambridge, Massachusetts, United States
Apple Tree PartnersSenior Associate2019New York, New York, United States
Apple Tree PartnersAssociate2016 — 2019New York, New York, United States
Elstar Therapeutics Inc.Board Observer2017 — 2019Cambridge, MA
Elstar Therapeutics Inc.Director, Business Development and Corporate Strategy2017 — 2019Cambridge, MA
MIFCOR, Inc.Co-Founder, Head of R&D2014 — 2017
Harvard UniversityGraduate Researcher and Postdoctoral Fellow2010 — 2016Greater Boston Area
Flagship VenturesVentureLabs Fellow and Consultant2015 — 2016Cambridge, MA
UC BerkeleyStaff Research Associate2008 — 2010Berkeley, CA
UC BerkeleyTutor/Study Group Facilitator2006 — 2009Berkeley, CA
Dynavax TechnologiesResearch Assistant - Intern2007Berkeley, CA

Skills & more

Molecular Biology32Flow Cytometry13Cell Culture18Western Blotting7Tissue Culture5Cell Biology45ELISA5Molecular Cloning13In Vitro5qPCR3Laboratory7Microbiology13

+4 more

Fluorescence MicroscopyOncologyImmunologyStudent Leadership

Languages English · Slovenian

From Jernej's professional profile.

Investments

Board seats

Caldera TherapeuticsDiagonal TherapeuticsEthyreal BioMariana OncologyTriana Biomedicines

Per the firm's website.

Colleagues at Atlas Venture

Aimee Raleigh

Principal at Atlas Venture

Bruce Booth

Partner at Atlas Venture

Chelsea Johnson

Principal at Atlas Venture

David Grayzel

Partner at Atlas Venture

Jason Rhodes

Partner at Atlas Venture

Jean-François Formela

Partner at Atlas Venture

Jodie Morrison

Venture Partner at Atlas Venture

Josh Powers

Associate at Atlas Venture

Frequently asked questions

Who is Jernej Godec?: Jernej Godec is a Principal at Atlas Venture, where he works on building therapeutics companies and supporting company creation across multiple therapeutic areas. Before Atlas, he was on the investment team at Apple Tree Partners, focused on early-stage therapeutics investments and company formation. He holds a PhD in immunology from Harvard University, where he studied T cell biology, and a BA with honors in molecular and cell biology from UC Berkeley.
Where does Jernej Godec work?: Jernej Godec is Principal at Atlas Venture.
What does Jernej Godec invest in?: Jernej Godec invests in Biotech.
What check size does Jernej Godec write?: Jernej Godec typically writes checks of $10M – $50M.
What boards does Jernej Godec sit on?: Jernej Godec holds tracked board seats at Caldera Therapeutics, Diagonal Therapeutics, Ethyreal Bio, Mariana Oncology, Triana Biomedicines.
Where did Jernej Godec go to school?: Jernej Godec studied at Harvard University (Ph.D., Immunology); University of California, Berkeley (B.A., with Honors in Molecular and Cell Biology).

Same school

Also attended Harvard University1,558

Alfred LinPartner at Sequoia Capital Chris DixonFounder & Managing Partner of a16z crypto at Andreessen Horowitz Sarah TavelVenture Partner at Benchmark Danny RimerPartner at Index Ventures Laela SturdyManaging Partner at CapitalG Bill GatesCo-founder of Microsoft; Chair of the Gates Foundation

+ 1,552 more

Also attended University of California, Berkeley1,453

Byron DeeterPartner at Bessemer Venture Partners Steve WozniakCo-founder of Apple Tony XuCo-founder & CEO of DoorDash Aravind SrinivasCo-founder & CEO of Perplexity AI Ali GhodsiCo-founder & CEO of Databricks Ryan PetersenFounder & CEO of Flexport

+ 1,447 more

Shared employers

Also worked at Atlas Venture61

Karim FarisInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla Ventures Kristen LaguerreExecutive Partner at MPM BioImpact Gretchen McCareyChief Financial Officer at Castle Island Ventures Kate GunioController at Long Ridge Equity Partners Henri MoissinacInvestor at FELIX CAPITAL

+ 55 more

Also worked at Apple Tree Partners8

Victor RusuPrincipal at MPM BioImpact Samuel HallManaging Partner at Scion Life Sciences Aaron KantoffManaging Partner at Scion Life Sciences Andreas LoewPartner at Scion Life Sciences Huw NashVenture Partner at Scion Life Sciences Christine BorowskiVice President at Access Biotechnology

+ 2 more

Also worked at Harvard University293

Nathan BlecharczykCo-founder & CSO of Airbnb Ryan SheaCo-founder of Blockstack (Stacks)Rachel HansenInvestor at Index Ventures Dave MunichielloInvestor at GV (Google Ventures)Logan HilleLife Sciences Analyst at CincyTech Walter KowtoniukInvestor at Third Rock Ventures

+ 287 more

Also worked at Flagship Ventures76

Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship Pioneering Samir KaulInvestor at Khosla Ventures Cassidy BlundellPartner at Mission Biocapital David KoleskyPrincipal at MPM BioImpact Diana BernsteinDirector at Northpond Ventures

+ 70 more